Actively Recruiting

Age: 45Years - 85Years
All Genders
Healthy Volunteers
ID06335836

The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in Subjective Cognitive Decline (SCD)

Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2024-03-28

209

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating how social isolation and social interaction affect the risk of dementia progression and brain function in people with Subjective Cognitive Decline (SCD). The study aims to explore the link between social isolation, loneliness, and the development of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD), as well as to understand how genetic factors like APOEb54 allele influence this progression. The research also focuses on creating a model to predict cognitive decline from SCD to MCI and AD and to confirm if social interaction protects cognitive function in SCD patients. The study involves observing groups of SCD participants with different levels of social isolation, measured by the Lubben Social Network Scale (LSNS-6). Participants are categorized as socially isolated (LSNS-6 612) or non-socially isolated (LSNS-6 >12). Researchers will collect and analyze data on brain network connectivity, walking ability, and genetic markers like APOE genotyping. This observational study includes cohort follow-up over 3 to 5 years and uses various cognitive tests and imaging techniques. Participants will be assessed through cognitive tests such as MoCA, AVLT-H, and fMRI scans at enrollment and at 3- and 5-year intervals. Researchers will monitor the incidence of MCI and AD over about one year and evaluate changes in brain function and social interaction measures. The study includes questionnaires on loneliness, depression, and sleep quality, as well as dual-task walking tests to understand cognitive and physical abilities. Overall participation could last several years with regular assessments to track cognitive decline and brain health.

CONDITIONS

Brief Title

The Effects of Social Isolation and Social Interaction on the Risk of Dementia Progression and Brain Function in SCD (Subjective Cognitive Decline, SCD)

Who Can Participate

Age: 45Years - 85Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Self-perceived continuous cognitive decline compared with previous normal state, not related to acute events
  • Normal results on standard cognitive tests after adjusting for age, gender, and education, or do not meet criteria for mild cognitive impairment
  • Able to provide informed consent independently
  • Aged between 45 and 85 years
Not Eligible

You will not qualify if you...

  • Under 45 years or over 85 years of age
  • Diagnosis of vascular dementia or other central nervous system diseases
  • Hachinski Ischemic Scale score greater than 4
  • Unable to complete neuropsychological tests due to conditions like blindness, deafness, or severe language impairment
  • Drug abuse or alcohol dependency within the last 6 months
  • Currently enrolled in other cognition studies
  • Severe diabetes, cardiovascular, cerebrovascular, liver, kidney diseases, or psychiatric disorders
  • Contraindications to imaging such as claustrophobia, metallic implants, or electronic devices like pacemakers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - At enrollment

Participants undergo baseline assessments including APOE genotyping and brain imaging to evaluate cognitive and brain function.

1 visit (in-person)

Long-term Monitoring

Duration - Approximately 1 year

Participants are followed over an average of 1 year with repeated cognitive, behavioral, and brain function assessments to monitor the progression of cognitive decline.

Follow-up visits at 3 and 5 years for imaging and biomarker assessments

Trial Site Locations

Total: 1 location

1

The First Affiliated Hospital of Nanjing Medical University

Nanjing, China, Jiangsu, China, 210000

Actively Recruiting

Loading map...

Research Team

Z

Zhu Yi

S

Shi Chunxu

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Comparison of Cardiac [18F]-MFBG PET Versus [123I]-MIBG SPEC...

Parkinson Disease

Actively Recruiting

2 locations

An Open-label, Non-randomized, Multi-center Pivotal Phase 3 ...

Alzheimer Disease

Actively Recruiting

25 locations

A Phase I Study to Assess the Safety, Tolerability and Preli...

Alzheimer's Disease

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here